glp-1 and depression drugs linked to reduced symptoms via gut microbiome | Cell Press posted on the topic GLP-1 Receptor Agonists in Mood

Goal: Stimulate endogenous growth hormone release to support anabolic processes related to muscle growth, fat metabolism, and tissue repair [1] [2]

TB-500's proposed mechanisms include: Regulation of actin polymerisation to support cell mobility and wound healing Promotion of stem cell migration to injury sites Reduction of inflammation and scar tissue formation Support of angiogenesis and endothelial cell differentiation Possible cardioprotective effects under investigation Why Are Patients Seeking These Peptides

114 In a controlled study enrolling 20 participants who received the VLCKD, a significant improvement in biochemical parameters was observed after 8 weeks of KD adherence, which included a reduction in BMI, LDL-C, TGs, insulinemia, and liver transaminases

The science is still developing, and while we are excited to offer this cutting-edge treatment to our patients who would benefit, our focus remains on safe, thoughtful integration and transparency about what is known and what is still being studied

Solutions for Chronic Inflammation with GLOW Peptide Therapy: The GLOW Peptide protocol directly targets this inflammatory cascade